Yi-Chung Hsieh

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 3

Top Topics

Machine Learning

Antiretroviral Therapy

Hepatitis C Virus

Top Venues

Hepatology (Baltimore, Md.)

Journal of viral hepatitis

This page only lists publications with an associated author ORCID identifier.

Publications

Chien-Hao Huang, Jian-He Fan, Wen-Juei Jeng, Shu-Ting Chang, Chan-Keng Yang, Wei Teng, Tsung-Han Wu, Yi-Chung Hsieh, Wei-Ting Chen, Yi-Cheng Chen, I-Shyan Sheen, Yung-Chang Lin, Yung-Chang Lin
Innate-like bystander-activated CD38 + HLA-DR + CD8 + T cells play a pathogenic role in patients with chronic hepatitis C. Hepatology (Baltimore, Md.) 76 (3) (2022)
Yi-Chung Hsieh, Chih-Lang Lin, Chao-Hung Hung, Chien-Hung Chen, Shui-Yi Tung, Yung-Chang Lin, Tsung-Hui Hu, Sheng-Nan Lu, Rong-Nan Chien, I-Shyan Sheen
Real-world experience of elbasvir/grazoprevir in Taiwan: This study was focused on liver and renal adverse effects. Journal of viral hepatitis 27 (5) (2020)
Yi-Chung Hsieh, Wen-Juei Jeng, Chien-Hao Huang, Wei Teng, Wei-Ting Chen, Yi-Cheng Chen, Shi-Ming Lin, Dar-In Tai, Chun-Yen Lin, I-Shyan Sheen
Hepatic decompensation during paritaprevir/ritonavir/ombitasvir/dasabuvir treatment for genotype 1b chronic hepatitis C patients with advanced fibrosis and compensated cirrhosis. PloS one 13 (8) (2018)